On August 7, 2025, a draft law “On Amending the Federal Law ‘On Protection of Competition’” (hereinafter, the “Draft Law”) was published. Prepared by the Federal Antimonopoly Service (hereinafter, the “FAS”), it aims to significantly narrow the scope of antitrust immunities concerning the results of intellectual activity.

Lidings is pleased to invite you and your colleagues to a seminar on launching new drugs in the Russian market.

Regulatory incentives and objective economic realities are driving pharmaceutical companies to seek opportunities for launching new drugs. Such projects are now being conceived and implemented not only by innovative companies but also by players who have traditionally specialized in generics and biosimilars.

During our seminar, we will share our experience and propose effective, cost-efficient legal solutions to help businesses safely and promptly execute new launches at any stage.

Overview of changes in the sphere of information security and personal data (hereinafter referred to as the “PD”) that will affect the activities of organizations involved in the wholesale and retail trade of medicinal products. We remind you that starting from September 1, 2025, consents for PD processing must be stand-alone documents, separate from website Privacy Policies

Join us and fellow experts to explore why MCIA is emerging as a viable platform for Russian businesses in cross-border dispute resolution.

April 10^th, 2025 annual conference Pharmaceuticals – 2025: Legal Issues will take place in Moscow organized by Pravo.ru. Lidings lawyers take an active part in the event’s program.

As a strategic partner of the conference, we aimed to make the program rich and actual. Together with pharmaceutical industry experts and lawyers, we will discuss how the market has changed in 2024 and what awaits us in 2025.

On 10 February 2025, President Trump signed an executive order, "Pausing Foreign Corrupt Practices Act Enforcement to Further American Economic and National Security" ("EO"): Is anti-corruption compliance on pause?

The EO establishes a moratorium on new investigations and enforcement actions under the FCPA for 180 days (with the possibility of a 180-day extension) and directs the Attorney General to review current investigations and enforcement actions within the specified timeframe, along with a revision of the guidelines governing FCPA investigations.

On December 11, 2024, Moscow hosted XV Indian-Russian Business-Dialogue Forum. Organised by the Indian Business Alliance, the Business Council for Cooperation with India, the Moscow Government, and Roscongress, the event gathered together leading politicians, business leaders, and experts to discuss key economic issues and explore new opportunities for collaboration.

On November 7, 2024, Lidings held a round table discussion " Launch of Medicines and Pharmaceutical Substances in Russian and Indian Markets" as part of the business program of the Forum "Under One Sun: Russia-India. Business and Culture ", which took place in Delhi, November 6 - 8, 2024.

Highlights of the event in our overview.

On 6-8 November 2024 the international forum “Under One Sun: Russia-India. Business and Cultur” will take place in Delhi, India withing the 100th anniversary of the Russian Association for International Cooperation. The event is organized on the initiative of the Ministry of Foreign Affairs of the Russian Federation and the Trade Mission in India with the support of Lidings as a co-organizer of the business discussion.

During the forum on November 7 Lidings will hold a special round table “Launch of Medicines and Pharmaceutical Substances in Russian and Indian Markets” moderated by Lidings’ partner Boris Malakhov and counsel Natalya Thotahewage.

On 15 October, Lidings hosted a webinar for its clients to break down the legal aspects of critical information infrastructure (CII) security, focusing on the regulation applicable to the pharmaceutical and chemical (Pharma and FMCG) and healthcare industries.